IN3 Economic VALUE and Health System IMPACT of Remdesivir in Treating Hospitalized COVID-19 Patients in the United States
This study evaluated remdesivir ’s long-term cost-effectiveness and impact on health system capacities versus standard of care (SoC) for hospitalized COVID-19 patients in the United States (US).
Source: Value in Health - Category: International Medicine & Public Health Authors: F. Sun, S. Jeyakumar, N. Smith Source Type: research
More News: COVID-19 | International Medicine & Public Health | Laboratory Medicine | Study | USA Health